Table 7. Descriptive analysis of key variables in a subset of the primary study population who have previously participated in an MDA.

Variable	Region III (n = 80)		Region IV (n = 68)		Region V (n = 98)		Region X (n = 52)		Total (n = 298)
	Frequency	%	Frequency	%	Frequency	%	Frequency	%	Frequency	%
Other members of the household took pills at the same time
Yes	68	85.0%	61	89.7%	95	96.9%	36	69.2%	260	87.2%
No	3	3.8%	4	5.9%	2	2.0%	8	15.4%	17	5.7%
Don’t know	9	11.3%	3	4.4%	1	1.0%	8	15.4%	21	7.0%
Feeling about the number of pills received
Very happy	25	31.3%	17	25.0%	14	14.3%	4	7.7%	60	20.1%
Happy	19	23.8%	13	19.1%	43	43.9%	11	21.2%	86	28.9%
Neutral	31	38.8%	28	41.2%	29	29.6%	22	42.3%	110	36.9%
Unhappy	2	2.5%	6	8.8%	8	8.2%	5	9.6%	21	7.0%
Very unhappy	2	2.5%	4	5.9%	4	4.1%	7	13.5%	17	5.7%
Don’t know/Unsure	1	1.3%	0	0.0%	0	0.0%	3	5.8%	4	1.3%
Description of Information regarding the LF treatment
Not useful	5	6.3%	1	1.5%	0	0.0%	2	3.8%	8	2.7%
A little useful	10	12.5%	0	0.0%	2	2.0%	2	3.8%	14	4.7%
Neutral	26	32.5%	4	5.9%	4	4.1%	6	11.5%	40	13.4%
Useful	11	13.8%	33	48.5%	34	34.7%	18	34.6%	96	32.2%
Very useful	24	30.0%	28	41.2%	58	59.2%	18	34.6%	128	43.0%
Don’t know/Didn’t receive info	4	5.0%	2	2.9%	0	0.0%	6	11.5%	12	4.0%
Opinion on LF drug safety
Very dangerous	0	0.0%	0	0.0%	0	0.0%	0	0.0%	0	0.0%
Dangerous	1	1.3%	2	2.9%	3	3.1%	1	1.9%	7	2.3%
Neutral	17	21.3%	6	8.8%	8	8.2%	7	13.5%	38	12.8%
Safe	13	16.3%	13	19.1%	13	13.3%	26	50.0%	65	21.8%
Very safe	47	58.8%	44	64.7%	73	74.5%	13	25.0%	177	59.4%
Don’t know	2	2.5%	3	4.4%	1	1.0%	5	9.6%	11	3.7%